In vitro susceptibility of isolates of Francisella tularensis types A and B from North America

Abstract

Due to concern that Francisella tularensis, the causative agent of tularemia, may be used as a bioterrorist weapon, the Clinical and Laboratory Standards Institute recently provided a susceptibility testing method with breakpoints. Here, 169 isolates (92 type A and 77 type B) from North America were tested against seven antimicrobial agents (streptomycin, gentamicin, tetracycline, doxycycline, ciprofloxacin, levofloxacin, and chloramphenicol) used for the treatment of tularemia. The MICs for all of the isolates fell within the susceptible range. In addition, all isolates had MICs for erythromycin of 0.5 to 4 μg/ml, in contrast to an MIC of >256 μg/ml for the common laboratory strain LVS (live vaccine strain). Copyright © 2008, American Society for Microbiology. All Rights Reserved.